PT Millennium Pharmacon International Tbk (SDPC.JK)
IDR 132.0
(0.76%)
IDR 132.0
(0.76%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1639.68 Billion IDR | 16.99% |
| 2022 | 1401.5 Billion IDR | 16.17% |
| 2021 | 1206.38 Billion IDR | 3.57% |
| 2020 | 1164.82 Billion IDR | -5.36% |
| 2019 | 1230.84 Billion IDR | 3.18% |
| 2018 | 1192.89 Billion IDR | 27.17% |
| 2017 | 938 Billion IDR | 27.89% |
| 2016 | 733.44 Billion IDR | 15.83% |
| 2015 | 633.21 Billion IDR | 19.48% |
| 2014 | 529.99 Billion IDR | 12.36% |
| 2013 | 471.67 Billion IDR | 22.32% |
| 2012 | 385.6 Billion IDR | 19.21% |
| 2011 | 323.46 Billion IDR | 16.98% |
| 2010 | 276.51 Billion IDR | 3.17% |
| 2009 | 268.01 Billion IDR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1805.64 Billion IDR | -3.57% |
| 2024 Q3 | 1783.74 Billion IDR | -1.21% |
| 2024 Q1 | 1872.43 Billion IDR | 14.19% |
| 2023 FY | 1639.68 Billion IDR | 16.99% |
| 2023 Q3 | 1551.77 Billion IDR | 1.16% |
| 2023 Q1 | 1472.97 Billion IDR | 5.1% |
| 2023 Q4 | 1639.68 Billion IDR | 5.66% |
| 2023 Q2 | 1533.99 Billion IDR | 4.14% |
| 2022 Q2 | 1263.55 Billion IDR | -2.89% |
| 2022 Q3 | 1371.57 Billion IDR | 8.55% |
| 2022 FY | 1401.5 Billion IDR | 16.17% |
| 2022 Q4 | 1401.5 Billion IDR | 2.18% |
| 2022 Q1 | 1301.09 Billion IDR | 7.85% |
| 2021 Q2 | 1256.93 Billion IDR | 3.76% |
| 2021 Q1 | 1211.43 Billion IDR | 4.0% |
| 2021 FY | 1206.38 Billion IDR | 3.57% |
| 2021 Q4 | 1206.38 Billion IDR | -13.76% |
| 2021 Q3 | 1398.91 Billion IDR | 11.3% |
| 2020 FY | 1164.82 Billion IDR | -5.36% |
| 2020 Q2 | 1222.68 Billion IDR | -7.19% |
| 2020 Q4 | 1164.82 Billion IDR | -1.34% |
| 2020 Q1 | 1317.4 Billion IDR | 7.03% |
| 2020 Q3 | 1180.62 Billion IDR | -3.44% |
| 2019 Q2 | 1289.45 Billion IDR | 0.49% |
| 2019 FY | 1230.84 Billion IDR | 3.18% |
| 2019 Q4 | 1230.84 Billion IDR | -2.46% |
| 2019 Q1 | 1283.23 Billion IDR | 7.57% |
| 2019 Q3 | 1261.9 Billion IDR | -2.14% |
| 2018 Q2 | 1013.42 Billion IDR | 12.06% |
| 2018 FY | 1192.89 Billion IDR | 27.17% |
| 2018 Q4 | 1192.89 Billion IDR | 7.94% |
| 2018 Q3 | 1105.12 Billion IDR | 9.05% |
| 2018 Q1 | 904.34 Billion IDR | -3.59% |
| 2017 Q2 | 850.45 Billion IDR | 14.5% |
| 2017 Q4 | 938 Billion IDR | 8.67% |
| 2017 Q3 | 863.14 Billion IDR | 1.49% |
| 2017 FY | 938 Billion IDR | 27.89% |
| 2017 Q1 | 742.77 Billion IDR | 1.27% |
| 2016 Q1 | 626.77 Billion IDR | -1.02% |
| 2016 FY | 733.44 Billion IDR | 15.83% |
| 2016 Q2 | 750.1 Billion IDR | 19.68% |
| 2016 Q3 | 716.89 Billion IDR | -4.43% |
| 2016 Q4 | 733.44 Billion IDR | 2.31% |
| 2015 Q3 | 611.17 Billion IDR | -2.02% |
| 2015 Q1 | 544.25 Billion IDR | 2.69% |
| 2015 FY | 633.21 Billion IDR | 19.48% |
| 2015 Q4 | 633.21 Billion IDR | 3.61% |
| 2015 Q2 | 623.79 Billion IDR | 14.61% |
| 2014 Q3 | 506.92 Billion IDR | 8.7% |
| 2014 FY | 529.99 Billion IDR | 12.36% |
| 2014 Q4 | 529.99 Billion IDR | 4.55% |
| 2014 Q1 | 442.33 Billion IDR | -6.22% |
| 2014 Q2 | 466.36 Billion IDR | 5.43% |
| 2013 Q4 | 471.67 Billion IDR | 7.81% |
| 2013 Q1 | 377.04 Billion IDR | -2.22% |
| 2013 Q3 | 437.49 Billion IDR | 7.67% |
| 2013 Q2 | 406.31 Billion IDR | 7.76% |
| 2013 FY | 471.67 Billion IDR | 22.32% |
| 2012 Q4 | 385.6 Billion IDR | 3.02% |
| 2012 Q3 | 374.3 Billion IDR | 0.0% |
| 2012 FY | 385.6 Billion IDR | 19.21% |
| 2011 FY | 323.46 Billion IDR | 16.98% |
| 2010 FY | 276.51 Billion IDR | 3.17% |
| 2009 FY | 268.01 Billion IDR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 10955.84 Billion IDR | 85.034% |
| PT Itama Ranoraya Tbk | 1058.88 Billion IDR | -54.85% |
| PT Kimia Farma (Persero) Tbk | 17585.29 Billion IDR | 90.676% |
| PT Soho Global Health Tbk | 4746.96 Billion IDR | 65.458% |